Latest news
Loading news…
Ensol Biosciences
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Taejon, Taejon-jikhalsi, South Korea Founded 2001 11-50 employees For Profit
Ensol Biosciences develops protein-based drugs for cancer, neurodegenerative, and muscle diseases using advanced bioengineering.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
17
3 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 14
- Patents granted
- 17
- Trademarks
- 3
- Top patent class
- Medical Or Veterinary Science; Hygiene
Company Info
- Founded
- 2001
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 7
- HQ
- Taejon, Taejon-jikhalsi, South Korea
- Region
- Asia-Pacific (APAC)
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- 1.3
- Trend (90d)
- 2.4
Key People at Ensol Biosciences
CEO
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Ensol Biosciences
Loading news…
FAQs about Ensol Biosciences
People who checked this page also checked these
Browse the full Acquirezy directory.